Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase

Our data suggest that primary brain tumours contain distinct subpopulations of cells that have high expression levels of ALDH and BTIC characteristics. ALDH might be a potential therapeutic target applicable to primary brain tumours.